Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

[Effect of haloperidol and risperidone on neuromarkers and indices of endothelial dysfunction in patients with acute schizophrenia].

Govorin NV, Vasil'eva AI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(3):54-7. Russian.

PMID:
21423116
2.
3.

Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.

Kudlek Mikulic S, Mihaljevic-Peles A, Sagud M, Bajs Janovic M, Ganoci L, Grubisin J, Kuzman Rojnic M, Vuksan Cusa B, Bradaš Z, Božina N.

Nord J Psychiatry. 2017 Oct;71(7):513-520. doi: 10.1080/08039488.2017.1340518. Epub 2017 Jul 2.

PMID:
28671000
4.

Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.

Zhang XY, Zhou DF, Shen YC, Zhang PY, Zhang WF, Liang J, Chen DC, Xiu MH, Kosten TA, Kosten TR.

Neuropharmacology. 2012 Apr;62(5-6):1928-34. doi: 10.1016/j.neuropharm.2011.12.014. Epub 2011 Dec 30.

PMID:
22227558
5.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
6.

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.

Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R.

World J Biol Psychiatry. 2012 Jan;13(1):30-8. doi: 10.3109/15622975.2011.552633. Epub 2011 May 13.

PMID:
21568628
7.
8.

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.

Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.

Am J Psychiatry. 2005 Oct;162(10):1888-95.

PMID:
16199835
9.

An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.

Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.

Kathmandu Univ Med J (KUMJ). 2006 Apr-Jun;4(2):152-60.

PMID:
18603890
10.
11.

Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.

Rizos EN, Papadopoulou A, Laskos E, Michalopoulou PG, Kastania A, Vasilopoulos D, Katsafouros K, Lykouras L.

World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):251-5. doi: 10.3109/15622970802182733.

PMID:
20218789
12.

Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment.

Minutolo G, Petralia A, Dipasquale S, Aguglia E.

Expert Opin Pharmacother. 2012 Oct;13(14):1989-97. doi: 10.1517/14656566.2012.713346. Epub 2012 Aug 28.

PMID:
22924902
13.

Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.

Smesny S, Langbein K, Rzanny R, Gussew A, Burmeister HP, Reichenbach JR, Sauer H.

Schizophr Res. 2012 Jul;138(2-3):164-70. doi: 10.1016/j.schres.2012.02.031. Epub 2012 Apr 17.

PMID:
22516552
14.

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Int Clin Psychopharmacol. 2001 Nov;16(6):325-30.

PMID:
11712620
15.

First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.

Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M.

Psychiatr Danub. 2011 Dec;23(4):384-8.

16.

Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.

Lee SM, Chou YH, Li MH, Wan FJ, Yen MH.

J Psychiatr Res. 2008 Mar;42(4):328-35. Epub 2007 Apr 6.

PMID:
17412363
17.

The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.

Rémillard S, Pourcher E, Cohen H.

Schizophr Res. 2005 Dec 1;80(1):99-106. Epub 2005 Sep 12.

PMID:
16162401
18.

Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.

Citrome L, Meng X, Hochfeld M, Stahl SM.

Hum Psychopharmacol. 2012 Jan;27(1):24-32. doi: 10.1002/hup.1254. Epub 2011 Dec 7.

PMID:
22161738
19.

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G; Early Psychosis Global Working Group.

Am J Psychiatry. 2005 May;162(5):947-53.

PMID:
15863797
20.

[Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].

López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL Jr, González Pinto A, Eguiluz I, Fernández A.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996 Jul-Aug;24(4):165-72. Spanish.

PMID:
8984849

Supplemental Content

Support Center